AIM: To determine whether inpatient diabetes management and education with improved transition to outpatient care (IDMET) improves glycemic control after hospital discharge in patients with uncontrolled type 2 diabetes (T2DM). METHODS:Adult inpatients with T2DM and HbA1c > 7.5% (58 mmol/mol) admitted for reasons other than diabetes to an academic medical center were randomly assigned to either IDMET or usual care (UC). Linear mixed models estimated treatment-dependent differences in the change in HbA1c (measured at 3, 6, and 12 months) from baseline to 1-year follow-up. RESULTS:Thirty-one subjects had mean age 55 ± 12.6 years, with mean HbA1c of 9.7 ± 1.6% (82 ± 18 mmol/mol). Mean inpatient glucose was lower in the IDMET than in the UC group (176 ± 66 versus 195 ± 74 mg/dl [9.7 versus 10.8 mmol/l], P = 0.001). In the year after discharge, the average HbA1c reduction was greater in the IDMET group compared with the UC group by 0.6% (SE 0.5%, [7 (SE 5)mmol/mol], P = 0.3). Among patients newly discharged on insulin, the average HbA1c reduction was greater in the in the IDMET group than in the UC group by 2.4% (SE 1.0%, [25 (SE 11)mmol/mol], P = 0.04). CONCLUSIONS:Inpatient diabetes management (IDMET) substantially improved glycemic control 1 year after discharge in patients newly discharged on insulin; patients previously treated with insulin did not benefit.
RCT Entities:
AIM: To determine whether inpatient diabetes management and education with improved transition to outpatient care (IDMET) improves glycemic control after hospital discharge in patients with uncontrolled type 2 diabetes (T2DM). METHODS: Adult inpatients with T2DM and HbA1c > 7.5% (58 mmol/mol) admitted for reasons other than diabetes to an academic medical center were randomly assigned to either IDMET or usual care (UC). Linear mixed models estimated treatment-dependent differences in the change in HbA1c (measured at 3, 6, and 12 months) from baseline to 1-year follow-up. RESULTS: Thirty-one subjects had mean age 55 ± 12.6 years, with mean HbA1c of 9.7 ± 1.6% (82 ± 18 mmol/mol). Mean inpatient glucose was lower in the IDMET than in the UC group (176 ± 66 versus 195 ± 74 mg/dl [9.7 versus 10.8 mmol/l], P = 0.001). In the year after discharge, the average HbA1c reduction was greater in the IDMET group compared with the UC group by 0.6% (SE 0.5%, [7 (SE 5)mmol/mol], P = 0.3). Among patients newly discharged on insulin, the average HbA1c reduction was greater in the in the IDMET group than in the UC group by 2.4% (SE 1.0%, [25 (SE 11)mmol/mol], P = 0.04). CONCLUSIONS: Inpatient diabetes management (IDMET) substantially improved glycemic control 1 year after discharge in patients newly discharged on insulin; patients previously treated with insulin did not benefit.
Authors: Stephen Clement; Susan S Braithwaite; Michelle F Magee; Andrew Ahmann; Elizabeth P Smith; Rebecca G Schafer; Irl B Hirsch; Irl B Hirsh Journal: Diabetes Care Date: 2004-02 Impact factor: 19.112
Authors: Harvey Jay Cohen; John R Feussner; Morris Weinberger; Molly Carnes; Ronald C Hamdy; Frank Hsieh; Ciaran Phibbs; Donald Courtney; Kenneth W Lyles; Conrad May; Cynthia McMurtry; Leslye Pennypacker; David M Smith; Nina Ainslie; Thomas Hornick; Kayla Brodkin; Philip Lavori Journal: N Engl J Med Date: 2002-03-21 Impact factor: 91.245
Authors: Christian S Göbl; Barbara Dobes; Anton Luger; Martin G Bischof; Michael Krebs Journal: Wien Klin Wochenschr Date: 2010-06-25 Impact factor: 1.704
Authors: Christopher O Phillips; Scott M Wright; David E Kern; Ramesh M Singa; Sasha Shepperd; Haya R Rubin Journal: JAMA Date: 2004-03-17 Impact factor: 56.272
Authors: Naina Sinha Gregory; Jane J Seley; Savira Kochhar Dargar; Naveen Galla; Linda M Gerber; Jennifer I Lee Journal: Curr Diab Rep Date: 2018-06-21 Impact factor: 4.810
Authors: Maryam T Fazel; Mohammad Fazel; Nora L Bedrossian; Fernando Picazo; Julia D Sobel; Mahdieh Fazel; Charisse Te; Merri L Pendergrass Journal: Adv Med Educ Pract Date: 2017-09-28
Authors: Andrew P Demidowich; Kristine Batty; Teresa Love; Sam Sokolinsky; Lisa Grubb; Catherine Miller; Larry Raymond; Jeanette Nazarian; M Shafeeq Ahmed; Leo Rotello; Mihail Zilbermint Journal: J Diabetes Sci Technol Date: 2021-02-20